4.2 Article

Constitutional Ring Chromosome 11 Mosaicism in a Wilms Tumor Patient: Cytogenetic, Molecular and Clinico-Pathological Studies

期刊

AMERICAN JOURNAL OF MEDICAL GENETICS PART A
卷 152A, 期 7, 页码 1756-1763

出版社

WILEY
DOI: 10.1002/ajmg.a.33420

关键词

ring chromosome 11; 11p15 duplication; Wilms tumor; SNPs array

资金

  1. Associazione Bianca Garavaglia, Busto Arsizio, Varese
  2. Italian Association for Cancer Research (AIRC)

向作者/读者索取更多资源

We report on a boy with three cell lines: 46,XY, r(11)(p15.5, q25)[90]/45,XY,-11 [8]/47,XY, r(11)(p15.5,q25)x2[2], with minor anomalies and mental retardation who developed asynchronous bilateral Wilms tumors (WTs). Array comparative genomic hybridization (CGH) performed on peripheral blood leukocytes of the patient led to the identification of a constitutional duplication of 4.8 Mb at 11p15.5-11p15.4. This duplication was found to involve the chromosome of paternal origin, and occurred in tandem on the ring chromosome 11. Despite the constitutive duplication of the paternal 11p15 chromosome region, the patient showed no sign of Beckwith-Wiedemann syndrome. However, the molecular characterization of the two neoplasias was consistent with their independent origin and showed that they arose from the two distinct cellular clones with the ring chromosome, indicating that this anomaly is likely to have caused the patient's susceptibility to WT development. (C) 2010 Wiley-Liss, Inc.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.2
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Letter Genetics & Heredity

New clinical features in an adult patient with Skraban-Deardorff syndrome

Giovanni Innella, Emanuela Scarano, Pietro Palumbo, Massimo Carella, Giulia Severi

AMERICAN JOURNAL OF MEDICAL GENETICS PART A (2023)

Review Oncology

The pathophysiology of bilateral and multifocal Wilms tumors: What we can learn from the study of predisposition syndromes

Nils Welter, Jack Brzezinski, Amy Treece, Murali Chintagumpala, Matthew D. Young, Daniela Perotti, Kathleen Kieran, Marjolijn C. J. Jongmans, Andrew J. Murphy

Summary: Approximately 5% of Wilms tumor patients have synchronous bilateral disease, indicating a genetic or epigenetic predisposition. This review article focuses on the genetic and epigenetic factors related to the development of synchronous bilateral Wilms tumor, with emphasis on alterations in 11p15.5 and specific genes like WT1, TRIM28, and REST. The article also identifies priority areas for international collaborative research to better understand the relationship between genetic or epigenetic factors and chemotherapy response, oncologic outcomes, and long-term renal function.

PEDIATRIC BLOOD & CANCER (2023)

Article Oncology

Relapse after nonmetastatic rhabdomyosarcoma: Salvage rates and prognostic variables

Luca Bergamaschi, Stefano Chiaravalli, Virginia Livellara, Giovanna Sironi, Nadia Puma, Olga Nigro, Giovanna Gattuso, Roberto Luksch, Monica Terenziani, Filippo Spreafico, Cristina Meazza, Marta Podda, Veronica Biassoni, Elisabetta Schiavello, Shushan Hovsepyan, Carlo Morosi, Sabina Vennarini, Maura Massimino, Michela Casanova, Andrea Ferrari

Summary: This study retrospectively analyzed the treatment of relapsing rhabdomyosarcoma patients and found that the survival rate after the first relapse is poor. Several factors were found to influence survival rates, and these factors can be used in a risk-adapted model to guide decisions for second-line treatments.

PEDIATRIC BLOOD & CANCER (2023)

Article Oncology

Establishment of 6 pediatric rhabdomyosarcoma patient's derived xenograft models closely recapitulating patients' tumor characteristics

Patrizia Gasparini, Michela Casanova, Giovanni Centonze, Cristina Borzi, Luca Bergamaschi, Paola Collini, Adele Testi, Stefano Chiaravalli, Maura Massimino, Gabriella Sozzi, Andrea Ferrari, Massimo Moro

Summary: This study established a series of pediatric RMS patient derived xenografts (PDXs) that closely mirrored the characteristics of the primary tumors. The grafting rate was higher for patients with worse prognosis. These PDX models serve as important tools for identifying potential treatments and developing personalized therapies.

TUMORI JOURNAL (2023)

Article Oncology

Secondary osteosarcoma: a challenge indeed

Cristina Meazza, Sironi Giovanna, Olga Nigro, Giovanna Gattuso, Barretta Francesco, Marta Podda, Roberto Luksch, Veronica Biassoni, Elisabetta Schiavello, Andrea Ferrari, Filippo Spreafico, Michela Casanova, Stefano Chiaravalli, Nadia Puma, Luca Bergamaschi, Virginia Livellara, Morosi Carlo, Antonina Parafioriti, Primo Daolio, Stefano Bastoni, Sabina Vennarini, Emilia Pecori, Ombretta Alessandro, Paola Collini, Maura Massimino, Monica Terenziani

Summary: This study examines the clinical characteristics and outcomes of patients with secondary osteosarcoma (SOS). The results show that the survival rates after SOS are lower than in patients with primary osteosarcoma but not negligible. Therefore, the best choice of treatment for such patients should be discussed at a referral center in terms of their chances of cure and quality of life.

INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY (2023)

Article Oncology

Should we reduce routine surveillance imaging in pediatric germ cell tumors?

Monica Terenziani, Francesco Barretta, Giovanna Gattuso, Gianni Bisogno, Massimo Conte, Alessandro Crocoli, Maria Debora De Pasquale, Davide Biasoni, Filippo Spreafico, Paolo D'Angelo

Summary: This study retrospectively investigated the site and detection method of relapses in children and adolescents with malignant germ cell tumors. It found that serum tumor markers identified a relapse in over 70% of cases, and according to the selection criteria published by Children Oncology Group in 2018, in over 90% of cases. These results highlight the importance of serum tumor markers as a relapse detection method, which could potentially reduce the need for radiology exams in specific subgroups.

PEDIATRIC BLOOD & CANCER (2023)

Correction Oncology

SELNET clinical practice guidelines for soft tissue sarcoma and GIST (vol 102, 102312, 2021)

J. Y. Blay, N. Hindi, J. Bollard, S. Aguiar Jr, M. Angel, B. Araya, R. Badilla, D. Bernabeu, F. Campos, C. H. S. Caro-Sanchez, B. Carvajal, A. Carvajal Montoya, S. Casavilca-Zambrano, V. Castro-Oliden, M. Chacon, M. Clara, P. Collini, R. Correa Genoroso, F. D. Costa, M. Cuellar, A. P. dei Tos, H. R. Dominguez Malagon, D. Donati, A. Dufresne, M. Eriksson, M. Farias-Loza, P. Fernandez, A. M. Frezza, T. Frisoni, D. Y. Garcia-Ortega, H. Gelderblom, F. Gouin, M. C. Gómez-Mateo, A. Gronchi, J. Haro, L. Huanca, N. Jimenez, M. Karanian, B. Kasper, B. B. Lopes David, A. Lopez-Pousa, G. Lutter, H. Martinez-Said, J. Martinez-Tlahuel, C. A. Mello, J. M. Morales Perez, S. Moura David, A. G. Nascimento, E. J. Ortiz-Cruz, E. Palmerini, S. Patel, Y. Pfluger, S. Provenzano, A. Righi, A. Rodriguez, R. Salas, T. T. G. Santos, K. Scotlandi, T. Soule, S. Stacchiotti, C. Valverde, F. Waisberg, E. Zamora Estrada, J. Martin-Broto

CANCER TREATMENT REVIEWS (2023)

Article Cell Biology

Effectiveness of irinotecan plus trabectedin on a desmoplastic small round cell tumor patient-derived xenograft

Valentina Zuco, Sandro Pasquali, Monica Tortoreto, Stefano Percio, Valentina Doldi, Marta Barisella, Paola Collini, Gian Paolo Dagrada, Silvia Brich, Patrizia Gasparini, Marco Fiore, Michela Casanova, Anna Maria Frezza, Alessandro Gronchi, Silvia Stacchiotti, Andrea Ferrari, Nadia Zaffaroni

Summary: This study used a patient-derived xenograft (PDX) model to evaluate the effectiveness of different drugs against desmoplastic small round cell tumor (DSRCT). It was found that doxorubicin, pazopanib, and larotrectenib had moderate antitumor effects, while trabectedin had higher activity. Vinorelbine, irinotecan, and eribulin achieved nearly complete tumor growth inhibition. The combination of irinotecan with either eribulin or trabectedin resulted in complete responses. This study highlights the importance of patient-derived preclinical models in exploring new treatments for DSRCT.

DISEASE MODELS & MECHANISMS (2023)

Article Biochemistry & Molecular Biology

Molecular Signature of Biological Aggressiveness in Clear Cell Sarcoma of the Kidney (CCSK)

Michele Fiore, Alberto Taddia, Valentina Indio, Salvatore Nicola Bertuccio, Daria Messelodi, Salvatore Serravalle, Jessica Bandini, Filippo Spreafico, Daniela Perotti, Paola Collini, Andrea Di Cataldo, Gianandrea Pasquinelli, Francesca Chiarini, Maura Fois, Fraia Melchionda, Andrea Pession, Annalisa Astolfi

Summary: Clear cell sarcoma of the kidney (CCSK) is a rare pediatric renal tumor with worse prognosis than Wilms' tumor. This study aims to investigate the molecular differences between metastatic and localized BCOR-ITD-positive CCSK at diagnosis. The findings suggest that metastatic CCSKs have an overexpression of genes related to the MAPK signaling pathway, and FGF3 may play a role in the acquisition of a more aggressive phenotype.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2023)

Editorial Material Oncology

Treating secondary malignant neoplasms: A burden of childhood cancer survivors

Marta G. Podda, Cristina Meazza, Giovanna Gattuso, Giovanna Sironi, Olga Nigro, Luca Bergamaschi, Veronica Biassoni, Michela Casanova, Stefano Chiaravalli, Andrea Ferrari, Roberto Luksch, Nadia Puma, Elisabetta Schiavello, Filippo Spreafico, Paolo Grampa, Siranoush Manoukian, Sabina Vennarini, Paola Collini, Primo A. Daolio, Massimiliano Gennaro, Marco Guzzo, Carlo Morosi, Davide Biasoni, Maura Massimino, Monica Terenziani

Summary: Each year, around 35,000 children and adolescents in Europe are diagnosed with cancer. Survival rates have increased to 80% in most European countries, thanks to chemotherapy, radiotherapy, and surgery. However, cancer survivors in childhood and adolescence face the risk of developing chronic health conditions and even second malignant neoplasms later in life. It is crucial to discuss potential problems early on and provide specialized care for these survivors.

TUMORI JOURNAL (2023)

Article Oncology

Long-term survivors with desmoplastic small round cell tumor (DSRCT): Results from a retrospective single-institution case series analysis

Claudia Giani, Stefano Radaelli, Rosalba Miceli, Lorenza Gandola, Claudia Sangalli, Anna Maria Frezza, Salvatore Provenzano, Sandro Pasquali, Rossella Bertulli, Marco Fiore, Dario Callegaro, Michela Casanova, Stefano Chiaravalli, Paola Collini, Gian Paolo Dagrada, Carlo Morosi, Nadia Zaffaroni, Paolo G. Casali, Andrea Ferrari, Alessandro Gronchi, Silvia Stacchiotti

Summary: A retrospective study on primary DSRCT was conducted to characterize long-term survivors (LTS). It was found that 13% of patients achieved cure, who had no liver or extra-abdominal metastasis at diagnosis, received complete surgery, and possibly underwent whole abdomino-pelvic radiotherapy (WAP-RT) and maintenance chemotherapy (MC).

CANCER MEDICINE (2023)

Article Oncology

Co-Occurrence of Beckwith-Wiedemann Syndrome and Early-Onset Colorectal Cancer

Francesco Cecere, Laura Pignata, Bruno Hay Mele, Abu Saadat, Emilia D'Angelo, Orazio Palumbo, Pietro Palumbo, Massimo Carella, Gioacchino Scarano, Giovanni Battista Rossi, Claudia Angelini, Angela Sparago, Flavia Cerrato, Andrea Riccio

Summary: This study reports a case of early-onset colorectal cancer (EO-CRC) in a 27-year-old woman with Beckwith-Wiedemann syndrome (BWSp). Genetic and epigenetic analysis revealed the presence of genetic and epigenetic variations that may be associated with the development of EO-CRC.

CANCERS (2023)

Article Oncology

Different states of stemness of glioblastoma stem cells sustain glioblastoma subtypes indicating novel clinical biomarkers and high-efficacy customized therapies

Alberto Visioli, Nadia Trivieri, Gandino Mencarelli, Fabrizio Giani, Massimiliano Copetti, Orazio Palumbo, Riccardo Pracella, Maria Grazia Cariglia, Chiara Barile, Luigi Mischitelli, Amata Amy Soriano, Pietro Palumbo, Federico Legnani, Francesco Dimeco, Leonardo Gorgoglione, Graziano Pesole, Angelo L. Vescovi, Elena Binda

Summary: This study demonstrates that distinct pools of GSCs enrich the functional inter-cluster variances in GBM patients. Two novel functional biomarkers that selectively represent GSCs pools were identified, capable of discriminating GBM patient stratification, survival, and drug response. These findings provide the groundwork for personalized diagnostic and prognostic strategies, as well as patient-selective treatment protocols.

JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2023)

Article Health Care Sciences & Services

Violence against Women and Stress-Related Disorders: Seeking for Associated Epigenetic Signatures, a Pilot Study

Andrea Piccinini, Paolo Bailo, Giussy Barbara, Monica Miozzo, Silvia Tabano, Patrizia Colapietro, Claudia Fare, Silvia Maria Sirchia, Elena Battaglioli, Paola Bertuccio, Giulia Manenti, Laila Micci, Carlo La Vecchia, Alessandra Kustermann, Simona Gaudi

Summary: Violence against women has negative consequences on their health. The EpiWE project aims to investigate the epigenetic signatures associated with intimate partner and sexual violence-induced stress-related disorders. The study found abnormal methylation levels of brain-derived neurotrophic factor, dopamine receptor D2, and insulin-like growth factor 2 genes in victims, indicating potential molecular pathways for addressing the long-term effects of violence and implementing precision medicine protocols.

HEALTHCARE (2023)

暂无数据